Fig. 1. Schematic of O-TPNVs for cancer immunotherapy.

(A) Schematic for the preparation of O-TPNVs. (B and C) Schematic for antitumor effects, including effects against tumor recurrence and metastasis after surgery, of O-TPNVs in vivo. i.v., intravenous.